News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
362,545 Results
Type
Article (22363)
Company Profile (31)
Press Release (340151)
Multimedia
Podcasts (77)
Webinars (7)
Section
Business (118712)
Career Advice (1409)
Deals (17274)
Drug Delivery (53)
Drug Development (41931)
Employer Resources (96)
FDA (8647)
Job Trends (8348)
News (189248)
Policy (16977)
Tag
Academia (1442)
Academic (1)
Accelerated approval (4)
Adcomms (10)
Allergies (52)
Alliances (33056)
ALS (58)
Alzheimer's disease (799)
Antibody-drug conjugate (ADC) (74)
Approvals (8680)
Artificial intelligence (171)
Autoimmune disease (14)
Automation (13)
Bankruptcy (156)
Best Places to Work (6986)
BIOSECURE Act (6)
Biosimilars (50)
Biotechnology (25)
Bladder cancer (58)
Brain cancer (11)
Breast cancer (188)
Cancer (1475)
Cardiovascular disease (113)
Career advice (1197)
Career pathing (24)
CAR-T (80)
Cell therapy (273)
Cervical cancer (14)
Clinical research (34163)
Collaboration (638)
Compensation (129)
Complete response letters (8)
COVID-19 (1414)
CRISPR (27)
C-suite (125)
Cystic fibrosis (54)
Data (1547)
Decentralized trials (2)
Denatured (25)
Depression (28)
Diabetes (189)
Diagnostics (3386)
Digital health (10)
Diversity (3)
Diversity, equity & inclusion (29)
Drug discovery (74)
Drug pricing (57)
Drug shortages (18)
Duchenne muscular dystrophy (67)
Earnings (55303)
Editorial (32)
Employer branding (12)
Employer resources (84)
Events (54651)
Executive appointments (402)
FDA (9498)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (5)
Funding (416)
Gene editing (64)
Generative AI (18)
Gene therapy (215)
GLP-1 (420)
Government (2243)
Grass and pollen (4)
Guidances (128)
Healthcare (10162)
Huntington's disease (12)
IgA nephropathy (17)
Immunology and inflammation (78)
Indications (22)
Infectious disease (1488)
Inflammatory bowel disease (96)
Inflation Reduction Act (8)
Influenza (27)
Intellectual property (64)
Interviews (264)
IPO (8313)
IRA (26)
Job creations (1712)
Job search strategy (993)
Kidney cancer (4)
Labor market (23)
Layoffs (212)
Leadership (16)
Legal (4383)
Liver cancer (36)
Lung cancer (217)
Lymphoma (99)
Machine learning (3)
Management (33)
Manufacturing (191)
MASH (50)
Medical device (6631)
Medtech (6635)
Mergers & acquisitions (9334)
Metabolic disorders (451)
Multiple sclerosis (52)
NASH (9)
Neurodegenerative disease (50)
Neuropsychiatric disorders (14)
Neuroscience (1121)
NextGen: Class of 2025 (3414)
Non-profit (2684)
Now hiring (5)
Obesity (223)
Opinion (153)
Ovarian cancer (46)
Pain (55)
Pancreatic cancer (52)
Parkinson's disease (86)
Partnered (12)
Patents (145)
Patient recruitment (61)
Peanut (24)
People (27208)
Pharmaceutical (9)
Pharmacy benefit managers (10)
Phase I (10201)
Phase II (14520)
Phase III (12189)
Pipeline (1069)
Policy (88)
Postmarket research (1638)
Preclinical (4520)
Press Release (31)
Prostate cancer (93)
Psychedelics (18)
Radiopharmaceuticals (146)
Rare diseases (234)
Real estate (2547)
Recruiting (37)
Regulatory (11564)
Reports (17)
Research institute (1316)
Resumes & cover letters (215)
Rett syndrome (2)
RNA editing (3)
RSV (23)
Schizophrenia (43)
Series A (74)
Series B (41)
Service/supplier (3)
Sickle cell disease (35)
Special edition (8)
Spinal muscular atrophy (68)
Sponsored (17)
Startups (1492)
State (1)
Stomach cancer (9)
Supply chain (30)
Tariffs (24)
The Weekly (51)
Vaccines (402)
Venture capitalists (19)
Weight loss (134)
Women's health (18)
Worklife (12)
Date
Today (135)
Last 7 days (627)
Last 30 days (1905)
Last 365 days (19150)
2025 (7245)
2024 (20200)
2023 (22242)
2022 (28001)
2021 (29823)
2020 (29131)
2019 (25096)
2018 (18581)
2017 (17502)
2016 (17037)
2015 (19390)
2014 (16256)
2013 (14243)
2012 (14064)
2011 (13505)
2010 (12696)
Location
Africa (535)
Alabama (40)
Alaska (4)
Arizona (87)
Arkansas (7)
Asia (21108)
Australia (3472)
California (3617)
Canada (1210)
China (314)
Colorado (179)
Connecticut (187)
Delaware (93)
Europe (49472)
Florida (630)
Georgia (138)
Idaho (21)
Illinois (304)
India (19)
Indiana (210)
Iowa (3)
Japan (115)
Kansas (58)
Kentucky (9)
Louisiana (4)
Maine (27)
Maryland (520)
Massachusetts (2779)
Michigan (126)
Minnesota (186)
Missouri (31)
Montana (8)
Nebraska (9)
Nevada (38)
New Hampshire (29)
New Jersey (1211)
New Mexico (12)
New York (1078)
North Carolina (625)
North Dakota (4)
Northern California (1600)
Ohio (107)
Oklahoma (11)
Oregon (18)
Pennsylvania (873)
Puerto Rico (1)
Rhode Island (20)
South America (744)
South Carolina (17)
Southern California (1397)
Tennessee (69)
Texas (532)
United States (14057)
Utah (122)
Virginia (82)
Washington D.C. (43)
Washington State (326)
West Virginia (2)
Wisconsin (28)
362,545 Results for "frost and sullivan".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
WuXi AppTec Named Global CRDMO Company of the Year by Frost & Sullivan for the Eighth Consecutive Year
October 30, 2024
·
2 min read
Press Releases
Science 37 Earns Frost & Sullivan’s 2024 Global Company of the Year Award for Decentralized Clinical Trials
September 16, 2024
·
2 min read
Business
Novotech Honored with Frost & Sullivan’s 2024 Best Practices Company of the Year Award for Leadership in Biotech CRO Services
September 11, 2024
·
3 min read
WuXi AppTec Named 2023 Global Contract Research, Development and Manufacturing Organization Company of the Year by Frost & Sullivan
WuXi AppTec received the 2023 Global Contract Research, Development and Manufacturing Organization Company of the Year Award from Frost & Sullivan, a growth advisory & growth opportunity analytics firm.
November 8, 2023
·
2 min read
Pharm Country
Curia wins 2023 Frost & Sullivan Customer Value Leadership Award
Curia, a leading contract research, development and manufacturing organization, announced it has been awarded a Best Practices Customer Value Leadership Award in the CRDMO industry by Frost & Sullivan.
June 29, 2023
·
2 min read
Frost & Sullivan white paper highlights the role of SmartRotate™ in improving radiography workflows
Image rotations were reduced by up to 91% according to Frost & Sullivan’s study of two hospitals using Agfa’s AI.
June 12, 2023
·
5 min read
Drug Development
Phesi Receives Frost & Sullivan’s Global Enabling Technology Leadership Award for Revolutionizing Clinical Development with Its Trial Accelerator Platform
September 4, 2024
·
5 min read
BioCapital
Adial Pharmaceuticals Wins Frost & Sullivan’s 2023 North American Precision Medicine for Addiction Disorders Technology Innovation Leadership Award
Adial Pharmaceuticals, Inc. announced that it has been awarded the 2023 Best Practices Technology Innovation Leadership Award in the North American precision medicine for addiction disorders industry by Frost & Sullivan, an American business consulting firm that offers market research and analysis, growth strategy consulting, and corporate training.
October 18, 2023
·
6 min read
Vetter earns Frost & Sullivan’s Customer Value Award for the third time
Identified as best-in-class CDMO in global biopharmaceutical aseptic fill-and-finish services
August 29, 2023
·
3 min read
New Research Launched at BIO24 Finds CROs with In-house Regulatory Affairs Deliver 30% Savings, Halve Timelines and Cut Risk for Biotechs
Avance Clinical, the award-winning Australian & North American market-leading CRO for biotechs, will share new research at BIO 2024 from Frost & Sullivan showing that biotechs can save more than 30% in costs, halve start-up times, and cut risk with CROs that have in-house scientific and regulatory affairs.
June 4, 2024
·
4 min read
1 of 36,255
Next
